'Severe combined immunodeficiency' presentation slideshows

PRIMARY IMMUNODEFICIENCY

1.68k views • 164 slides

Objectives

924 views • 62 slides

Ethics of Biotechnology

Ethics of Biotechnology. CLONING. What is CLONING?. Creating new and identical organisms using biotechnology. What does cloning PRODUCE?. A new organism identical to the donor organism. What are the STEPS to create a CLONE?. An EGG is taken from a Donor cell and the nucleus is removed

653 views • 37 slides

IMMUNODEFICIENCIES AGE AND HEALTH DEPENDENT IMMUNOSUPPRESSIVE DRUGS

INHERITED Loss of function mutation of genes of the immune system Enhanced susceptibility to infections Particular types of pathogens depending on the gene defect Did not stand out until 1950 - antibiotics. ACQUIRED Due to infectious diseases AIDS Other virus infections Malnutrition

513 views • 32 slides

Lymphatic System

879 views • 29 slides

Chapter 11-Nucleic Acids as Therapeutic Agents

Chapter 11-Nucleic Acids as Therapeutic Agents. Nucleic acids A ntisense RNA and oligonucleotides R ibozymes A ptamers , I nterfering RNAs or RNAi Gene therapy Stem cells and therapeutic cloning. Figure 11.1.

655 views • 24 slides

T-Lymphocyte Gene Transfer for a Patient with ADA-SCID

T-Lymphocyte Gene Transfer for a Patient with ADA-SCID. Onodera, M., T. Ariga, N. Kawamura, I. Koboyashi, M. Ohtsu, M. Yamada, A. Tame, H. Furuta, M. Okano, S. Matsumoto, H. Kotani, G.J. McGarrity, R. M. Blaese, and Y. Sakiyama. 1998. Blood. By: Anne Shields. What is ADA-SCID?.

666 views • 23 slides

Gene therapy progress and prospects cancer

Gene therapy progress and prospects cancer. Gene Therapy. P rimary challenge for gene therapy Successfully delivery an efficacious dose of a therapeutic gene to the disease tissue.

399 views • 18 slides